The clinical implications of spinal-fluid lactic dehydrogenase activity
N Engl J Med
.
1958 Mar 27;258(13):635-9.
doi: 10.1056/NEJM195803272581303.
Authors
F WROBLEWSKI
,
B DECKER
,
R WROBLEWSKI
PMID:
13517532
DOI:
10.1056/NEJM195803272581303
No abstract available
MeSH terms
Central Nervous System Diseases*
Cerebrospinal Fluid*
Humans
Oxidation-Reduction*
Oxidoreductases / cerebrospinal fluid*
Substances
Oxidoreductases